Over the last 12 months, Evommune insiders reported 2 buys totaling $146K and 9 sales totaling $2.3M across SEC Form 4 filings. 82% of the activity was filed under pre-arranged 10b5-1 trading plans.
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Carver KyleChief Financial Officer · O | ▲ Buy | 1,000 | $13.26 | $13K | +1.7% | — |
| Jul 7, 2026 | KIRSCH ARTHUR SD | ▲ Buy | 10,000 | $13.3 | $133K | — | indirect |
| Jun 22, 2026 | Drew Janice SuzannChief of Dev. Operations · O | ▼ Sale | 20,000 | $22.63 | $453K | -22.8% | plan |
| Jun 22, 2026 | Patel Jeegar PravinkumarChief Scientific Officer · O | ▼ Sale | 1,488 | $22.5 | $33K | -3.1% | plan |
| Jun 22, 2026 | Pena Luis C.President & CEO · O·D | ▼ Sale | 7,438 | $22.71 | $169K | -1.2% | plan |
| Jun 2, 2026 | Cohen David ED | ▼ Sale | 600 | $21.38 | $13K | -3.3% | plan |
| Jun 2, 2026 | Cohen David ED | ▼ Sale | 5,456 | $20.21 | $110K | -23.1% | plan |
| Jun 1, 2026 | Patel Jeegar PravinkumarChief Scientific Officer · O | ▼ Sale | 16,687 | $22.74 | $379K | -26.4% | plan |
| Jun 1, 2026 | Pena Luis C.President & CEO · O·D | ▼ Sale | 16,787 | $22.74 | $382K | -2.6% | plan |
| May 28, 2026 | Moss Gregory S.Chief Business & Legal Officer · O | ▼ Sale | 14,223 | $22.83 | $325K | -18.9% | plan |
| May 28, 2026 | Carver KyleChief Financial Officer · O | ▼ Sale | 18,175 | $22.84 | $415K | -23.4% | plan |
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $EVMN feed.